FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012015621> ?p ?o ?g. }

• W2012015621 endingPage "716" @default.
• W2012015621 startingPage "704" @default.
• W2012015621 abstract "The discovery of new therapeutic drugs with the ability of preventing inflammation and joint destruction with less adverse effects is extremely urgent for rheumatoid arthritis (RA). Cryptotanshinone (CTS), an active component isolated from the root of Salvia miltiorrhiza Bunge, has been reported to have antibacterial and antitumor effects. However, its effects on RA have not been clearly elucidated. Here, we investigated the therapeutic effect of CTS on type II collagen-induced arthritis (CIA) in rats and explored the underlying mechanisms. Our results revealed that CTS treatment efficaciously ameliorated inflammation and joint destruction of rats with CIA. Both in vivo and in vitro studies showed that CTS suppressed the production of proinflammatory cytokines including interleukin 1β, tumor necrosis factor alpha, and interleukin 17α production and downregulated the production and activity of matrix metalloproteinase 9. By receptor activator of nuclear factor kappa B (NF-κB) ligand-induced bone marrow macrophages, we observed that CTS could inhibit osteoclast differentiation, which is critic for joint destruction. Further studies on inflammatory signaling revealed that CTS could inhibit the degradation of inhibitor of NF-κB (IκB) α in vivo and in vitro, prevent the nuclear translocation of NF-κB p65 induced by lipopolysaccharide in a time- and dose-dependent manner. By electrophoretic mobility shift assay and luciferase reporter assay, we found that CTS distinctively inhibited the NF-κB DNA binding activity and NF-κB-dependent luciferase activity. These results indicate that the therapeutic effect of CTS on CIA is accomplished mainly through the inhibition of NF-κB signaling. Our findings provide the evidence to develop CTS as a potential therapeutic agent for patients with RA." @default.
• W2012015621 created "2016-06-24" @default.
• W2012015621 creator A5005727907 @default.
• W2012015621 creator A5009067006 @default.
• W2012015621 creator A5018863416 @default.
• W2012015621 creator A5021449466 @default.
• W2012015621 creator A5027649946 @default.
• W2012015621 creator A5038979265 @default.
• W2012015621 creator A5047998996 @default.
• W2012015621 creator A5056036725 @default.
• W2012015621 creator A5075777361 @default.
• W2012015621 creator A5083869537 @default.
• W2012015621 creator A5086514660 @default.
• W2012015621 date "2015-06-01" @default.
• W2012015621 modified "2023-10-14" @default.
• W2012015621 title "Therapeutic effect of Cryptotanshinone on collagen-induced arthritis in rats via inhibiting nuclear factor kappa B signaling pathway" @default.
• W2012015621 cites W149177015 @default.
• W2012015621 cites W1495086152 @default.
• W2012015621 cites W1564492456 @default.
• W2012015621 cites W1584068529 @default.
• W2012015621 cites W1945920109 @default.
• W2012015621 cites W1964342138 @default.
• W2012015621 cites W1989328345 @default.
• W2012015621 cites W1990714610 @default.
• W2012015621 cites W2005603603 @default.
• W2012015621 cites W2010802338 @default.
• W2012015621 cites W2020458523 @default.
• W2012015621 cites W2026152558 @default.
• W2012015621 cites W2026514475 @default.
• W2012015621 cites W2030148374 @default.
• W2012015621 cites W2038773223 @default.
• W2012015621 cites W2045891124 @default.
• W2012015621 cites W2059983531 @default.
• W2012015621 cites W2064711537 @default.
• W2012015621 cites W2066867846 @default.
• W2012015621 cites W2074438676 @default.
• W2012015621 cites W2079241115 @default.
• W2012015621 cites W2088244043 @default.
• W2012015621 cites W2093252878 @default.
• W2012015621 cites W2101707809 @default.
• W2012015621 cites W2106171259 @default.
• W2012015621 cites W2109658199 @default.
• W2012015621 cites W2131882149 @default.
• W2012015621 cites W2136466466 @default.
• W2012015621 cites W2140611998 @default.
• W2012015621 cites W2147156901 @default.
• W2012015621 cites W2148191159 @default.
• W2012015621 cites W2153865301 @default.
• W2012015621 cites W4313347845 @default.
• W2012015621 cites W4313376959 @default.
• W2012015621 doi "https://doi.org/10.1016/j.trsl.2014.12.004" @default.
• W2012015621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25605261" @default.
• W2012015621 hasPublicationYear "2015" @default.
• W2012015621 type Work @default.
• W2012015621 sameAs 2012015621 @default.
• W2012015621 citedByCount "23" @default.
• W2012015621 countsByYear W20120156212015 @default.
• W2012015621 countsByYear W20120156212016 @default.
• W2012015621 countsByYear W20120156212017 @default.
• W2012015621 countsByYear W20120156212018 @default.
• W2012015621 countsByYear W20120156212019 @default.
• W2012015621 countsByYear W20120156212020 @default.
• W2012015621 countsByYear W20120156212021 @default.
• W2012015621 countsByYear W20120156212022 @default.
• W2012015621 countsByYear W20120156212023 @default.
• W2012015621 crossrefType "journal-article" @default.
• W2012015621 hasAuthorship W2012015621A5005727907 @default.
• W2012015621 hasAuthorship W2012015621A5009067006 @default.
• W2012015621 hasAuthorship W2012015621A5018863416 @default.
• W2012015621 hasAuthorship W2012015621A5021449466 @default.
• W2012015621 hasAuthorship W2012015621A5027649946 @default.
• W2012015621 hasAuthorship W2012015621A5038979265 @default.
• W2012015621 hasAuthorship W2012015621A5047998996 @default.
• W2012015621 hasAuthorship W2012015621A5056036725 @default.
• W2012015621 hasAuthorship W2012015621A5075777361 @default.
• W2012015621 hasAuthorship W2012015621A5083869537 @default.
• W2012015621 hasAuthorship W2012015621A5086514660 @default.
• W2012015621 hasConcept C104317684 @default.
• W2012015621 hasConcept C123298856 @default.
• W2012015621 hasConcept C150903083 @default.
• W2012015621 hasConcept C164027704 @default.
• W2012015621 hasConcept C170493617 @default.
• W2012015621 hasConcept C171958077 @default.
• W2012015621 hasConcept C17991360 @default.
• W2012015621 hasConcept C183978625 @default.
• W2012015621 hasConcept C185592680 @default.
• W2012015621 hasConcept C202751555 @default.
• W2012015621 hasConcept C203014093 @default.
• W2012015621 hasConcept C207001950 @default.
• W2012015621 hasConcept C2776033226 @default.
• W2012015621 hasConcept C2776914184 @default.
• W2012015621 hasConcept C2777077863 @default.
• W2012015621 hasConcept C2777730290 @default.
• W2012015621 hasConcept C2778923194 @default.
• W2012015621 hasConcept C55493867 @default.
• W2012015621 hasConcept C62478195 @default.
• W2012015621 hasConcept C71924100 @default.
• W2012015621 hasConcept C86339819 @default.

• next